Morgan Stanley’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86.4K Sell
3,019
-381
-11% -$11.1K ﹤0.01% 6223
2025
Q4
$96.2K Buy
3,400
+382
+13% +$10.8K ﹤0.01% 6222
2025
Q3
$84.4K Buy
3,018
+332
+12% +$9.04K ﹤0.01% 6227
2025
Q2
$70.6K Buy
2,686
+686
+34% +$17K ﹤0.01% 6248
2025
Q1
$50.5K Hold
2,000
﹤0.01% 6263
2024
Q4
$49.5K Sell
2,000
-2
-0.1% -$52 ﹤0.01% 6292
2024
Q3
$50.8K Buy
2,002
+1
+0% +$24 ﹤0.01% 6219
2024
Q2
$46.6K Hold
2,001
﹤0.01% 6200
2024
Q1
$48K Sell
2,001
-2,001
-50% -$44.8K ﹤0.01% 6227
2023
Q4
$86.6K Buy
4,002
+2,002
+100% +$41.3K ﹤0.01% 6212
2023
Q3
$40.8K Sell
2,000
-2,422
-55% -$51K ﹤0.01% 6251
2023
Q2
$92.4K Hold
4,422
﹤0.01% 5990
2023
Q1
$87.7K Hold
4,422
﹤0.01% 6060
2022
Q4
$86.5K Hold
4,422
﹤0.01% 6049
2022
Q3
$79K Sell
4,422
-139
-3% -$2.73K ﹤0.01% 6197
2022
Q2
$87K Buy
+4,561
New +$92.9K ﹤0.01% 6349

Other funds holding REVS

Morgan Stanley's REVS Position: Q1 2026 in Review

Morgan Stanley reduced its Columbia Research Enhanced Value ETF (REVS) stake by 11% in Q1 2026, selling an estimated $11.1K and leaving 3,019 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6223.

Morgan Stanley first reported a position in REVS in Q2 2022 and has held it in 16 quarters since. The position peaked at $96.2K in Q4 2025. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • Morgan Stanley held 3,019 shares of Columbia Research Enhanced Value ETF worth $86.4K as of Q1 2026.
  • Morgan Stanley sold 381 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $11.1K.
  • Columbia Research Enhanced Value ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6223 holding.
  • Morgan Stanley first reported a position in Columbia Research Enhanced Value ETF in Q2 2022 and has held it in 16 quarters since.
  • Morgan Stanley's Columbia Research Enhanced Value ETF position peaked at $96.2K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.